GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GHRS is expected to report earnings to rise 35.74% to -31 cents per share on November 05
Q3'26
Est.
$-0.31
Q2'26
Beat
by $0.09
Q1'26
Missed
by $0.02
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.01
The last earnings report on August 06 showed earnings per share of -23 cents, beating the estimate of -31 cents. With 78.13K shares outstanding, the current market capitalization sits at 1.61B.